[PETDAG] QoQ Annualized Quarter Result on 30-Sep-2020 [#3]

Announcement Date
17-Nov-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Sep-2020 [#3]
Profit Trend
QoQ- 580.49%
YoY- -73.43%
View:
Show?
Annualized Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 20,494,616 20,413,272 18,710,947 19,088,185 18,971,322 26,215,640 30,293,571 -22.95%
PBT 750,842 1,141,824 386,421 361,373 -34,522 -73,712 1,128,872 -23.82%
Tax -203,784 -377,168 -114,007 -115,012 -17,532 -37,088 -291,237 -21.20%
NP 547,058 764,656 272,414 246,361 -52,054 -110,800 837,635 -24.74%
-
NP to SH 546,508 764,452 275,964 249,000 -51,822 -117,692 829,535 -24.30%
-
Tax Rate 27.14% 33.03% 29.50% 31.83% - - 25.80% -
Total Cost 19,947,558 19,648,616 18,438,533 18,841,824 19,023,376 26,326,440 29,455,936 -22.90%
-
Net Worth 5,613,015 5,672,622 5,642,818 5,662,687 5,503,735 5,553,408 5,980,593 -4.14%
Dividend
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Div 476,857 556,334 377,512 278,167 198,690 198,690 844,435 -31.70%
Div Payout % 87.26% 72.78% 136.80% 111.71% 0.00% 0.00% 101.80% -
Equity
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Net Worth 5,613,015 5,672,622 5,642,818 5,662,687 5,503,735 5,553,408 5,980,593 -4.14%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 993,454 0.00%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 2.67% 3.75% 1.46% 1.29% -0.27% -0.42% 2.77% -
ROE 9.74% 13.48% 4.89% 4.40% -0.94% -2.12% 13.87% -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 2,062.97 2,054.78 1,883.42 1,921.40 1,909.63 2,638.84 3,049.32 -22.95%
EPS 55.00 76.80 27.80 25.07 -5.20 -12.00 83.50 -24.31%
DPS 48.00 56.00 38.00 28.00 20.00 20.00 85.00 -31.70%
NAPS 5.65 5.71 5.68 5.70 5.54 5.59 6.02 -4.14%
Adjusted Per Share Value based on latest NOSH - 993,454
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
RPS 2,060.87 2,052.69 1,881.51 1,919.45 1,907.70 2,636.16 3,046.22 -22.95%
EPS 54.96 76.87 27.75 25.04 -5.21 -11.83 83.42 -24.30%
DPS 47.95 55.94 37.96 27.97 19.98 19.98 84.91 -31.70%
NAPS 5.6443 5.7042 5.6742 5.6942 5.5344 5.5843 6.0139 -4.14%
Price Multiplier on Financial Quarter End Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 -
Price 18.60 20.04 21.40 19.74 20.60 21.16 23.10 -
P/RPS 0.90 0.98 1.14 1.03 1.08 0.80 0.76 11.94%
P/EPS 33.81 26.04 77.04 78.76 -394.91 -178.61 27.66 14.33%
EY 2.96 3.84 1.30 1.27 -0.25 -0.56 3.61 -12.40%
DY 2.58 2.79 1.78 1.42 0.97 0.95 3.68 -21.09%
P/NAPS 3.29 3.51 3.77 3.46 3.72 3.79 3.84 -9.80%
Price Multiplier on Announcement Date
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Date 23/08/21 25/05/21 19/02/21 17/11/20 25/08/20 19/05/20 25/02/20 -
Price 18.80 18.82 19.20 19.50 21.22 20.22 21.40 -
P/RPS 0.91 0.92 1.02 1.01 1.11 0.77 0.70 19.13%
P/EPS 34.18 24.46 69.12 77.80 -406.80 -170.68 25.63 21.17%
EY 2.93 4.09 1.45 1.29 -0.25 -0.59 3.90 -17.37%
DY 2.55 2.98 1.98 1.44 0.94 0.99 3.97 -25.57%
P/NAPS 3.33 3.30 3.38 3.42 3.83 3.62 3.55 -4.17%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment